N. F. Voelkel - Concepedia

Author

N. F. Voelkel

University of Colorado Health

Also Known As

N F Voelkel, N Voelkel, N. F. Voelkel, N. Voelkel, N.F. Voelkel, NF Voelkel, Norbert F. Voelkel, Norbert Voelkel

102

Publications

Citations

H-Index

103

Concepts

All Affiliations

University of Colorado Health University of Colorado Denver National Jewish Health

About

N. F. Voelkel is an author at University of Colorado Health specializing in medicine, physiology, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	29	49	4.6K
2	Public Health	9	9	1.2K
3	Health Sciences	8	8	1.7K
4	Allergy	3	3	168
5	Engineering	2	2	225

N. F. Voelkel

Publications

Citations

H-Index

Page 1

	Year	Citations
Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension. Rubin M. Tuder, Bertron Μ. Groves, David B. Badesch, PubMed	1994	802
Increased gene expression for VEGF and the VEGF receptors KDR/Flk and Flt in lungs exposed to acute or to chronic hypoxia. Modulation of gene expression by nitric oxide. Rubin M. Tuder, B E Flook, N. F. Voelkel Journal of Clinical Investigation Acute Lung InjuryLung InflammationNitric OxideImmunologyOxidative Stress	1995	595
Changes in gene expression in the intact human heart. Downregulation of alpha-myosin heavy chain in hypertrophied, failing ventricular myocardium. Brian D. Lowes, Wayne Minobe, William T. Abraham, Journal of Clinical Investigation Cardiac MuscleHeart FailureGeneticsIdc RvsDiastolic Function	1997	501
Plasma and lipids from stored packed red blood cells cause acute lung injury in an animal model. Christopher C. Silliman, N. F. Voelkel, Jenny D. Allard, Journal of Clinical Investigation Acute Lung InjuryLung InflammationBlood CellInflammationHematology	1998	472
Monoclonal endothelial cell proliferation is present in primary but not secondary pulmonary hypertension. S. D. Lee, Kenneth R. Shroyer, Neil Markham, Journal of Clinical Investigation HypertensionVascular DiseaseEndothelial CellsLung InflammationPathology	1998	427
Platelet-activating factor mediates hemodynamic changes and lung injury in endotoxin-treated rats. Shih-Wen Chang, Christian Feddersen, Peter M. Henson, Journal of Clinical Investigation Acute Lung InjuryLung InflammationImmunologyLung Lavage PafPlatelet-activating Factor	1987	360
Proactive integrated care improves quality of life in patients with COPD Patricia B. Koff, R. H. Jones, Josphine Cashman, European Respiratory Journal	2009	220
Interleukin-1 receptor antagonist treatment reduces pulmonary hypertension generated in rats by monocrotaline. N. F. Voelkel, Rubin M. Tuder, James P. Bridges, American Journal of Respiratory Cell and Molecular Biology HypertensionInflammatory Lung DiseaseLung InflammationImmunologyPulmonary Hypertension	1994	207
Severe pulmonary hypertension and arterial adventitial changes in newborn calves at 4,300 m K.R. Stenmark, James W. Fasules, Dallas M. Hyde, Journal of Applied Physiology HypertensionSevere Pulmonary HypertensionPulmonary HypertensionNewborn CalvesPublic Health	1987	203
Leukotriene E4 elimination and metabolism in normal human subjects. Angelo Sala, N. F. Voelkel, Jacques Maclouf, Journal of Biological Chemistry EngineeringHealthy SubjectsLipid PeroxidationBioanalysisRadiopharmaceutical Therapy	1990	141

Page 1